Legend Biotech Corp. (LEGN) PT Raised to $49 at UBS

June 3, 2026 6:50 AM

UBS analyst Ashwani Verma raised the price target on Legend Biotech Corp. (NASDAQ: LEGN) to $49.00 (from $31.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found